Dr. Nikisha Kothari Selected as “One to Watch” in Retina Today
Texas Retina’s Dr. Nikisha Kothari has been selected as a “One to Watch” in the July/August issue of Retina Today. This feature highlights individuals identified as future leaders in the field of
read more
Texas Retina Research Team Members Attended Ollin Study Meeting in Maui
This past weekend, seven members of Texas Retina’s research team were invited to attend the Ollin Study Coordinators meeting in Maui, Hawaii. Ollin is a Phase Ib study of two different formulations
read more
Dr. Nikisha Kothari Leads Eyetube Interview on a Challenging Surgical Case
Texas Retina’s Nikisha Kothari, MD, recently interviewed one of the 2025 Vit-Buckle Society Meeting presenters about a challenging case for Eyetube. She talked with Andrew Tsai, MD, an adult and pediatric retinal
read more
Dr. Coors Treats First Patient in DAYBREAK Clinical Trial of Intravitreal Tarcocimab Tedromer and Tabirafusp Tedromer for Wet AMD
Texas Retina’s Lori E. Coors, MD, recently enrolled and treated the first patient in the Phase III DAYBREAK trial evaluating an intravitreal tarcocimab tedromer and tabirafusp tedromer compared with intravitreal aflibercept in
read more
Honoring Our Physicians
Tomorrow, March 30, is National Doctor’s Day. At Texas Retina, we celebrate all 16 of our physicians as well as all of the physicians who care for our patients and communities. Thank
read more